Fig. 2From: Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS)Nonlinear principal component analysis (PCA) on 24 gene variants used as variables, to investigate multivariate patterns of variation among the gene variants within the PGx–CNS sample (501 individuals). a PC1,2 (representing a partial amount of total sample variance of 28.01%) showed correlations among gene variants, distinctively forming four groups of individuals. b PC3,4 representing a partial amount of total sample variance of 11.6%, revealed the presence of two specimens with extreme scores (outliers)Back to article page